13F-HR filed by Birchview Capital, LP
Birchview Capital, LP filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-12, with 46 holding rows worth $112,738,000.
- Accession
- 0001618205-20-000002
- Filer
- CIK 1618205
- Filed
- 2020-05-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2020
A holdings report, 0 entries on the cover page, a total value of $112,738,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $112,738,000 with VALUE read as thousands by filing date, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | 110122108 | COM | 785,785 | $43,800,000 | thousands by filing date | |
| Accelerate Diagnostics | 00430H102 | COM | 2,193,795 | $18,274,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 74,000 | $6,405,000 | thousands by filing date | |
| QUIDEL CORP | 74838J101 | COM | 48,844 | $4,777,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 92,000 | $3,887,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 11,000 | $3,480,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 148,000 | $2,843,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122157 | RIGHT 99/99/9999 | 706,848 | $2,686,000 | thousands by filing date | |
| VERMILLION INC | 92407M206 | COM NEW | 3,221,933 | $2,682,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 18,000 | $1,707,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 18,672 | $1,678,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 170,303 | $1,577,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 20,000 | $1,495,000 | thousands by filing date | |
| CONTRAFECT CORP | 212326102 | COM | 255,700 | $1,473,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 8,000 | $1,417,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 30,000 | $1,205,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 60,000 | $931,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 22,000 | $924,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 80,000 | $829,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 48,000 | $786,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 180,000 | $720,000 | thousands by filing date | |
| HARROW INC | 415858109 | COM | 180,000 | $688,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 190,000 | $648,000 | thousands by filing date | |
| EQM MIDSTREAM PARTNERS LP | 26885B100 | UNIT LTD PARTN | 51,250 | $605,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 15,000 | $604,000 | thousands by filing date | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 50,000 | $594,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 20,000 | $552,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 8,300 | $523,000 | thousands by filing date | |
| SOLENO THERAPEUTICS INC | 834203101 | COM | 201,499 | $480,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 20,000 | $458,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 40,000 | $441,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 110,000 | $420,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 12,300 | $368,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 38,000 | $351,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 10,000 | $340,000 | thousands by filing date | |
| PROGYNY INC COM | 74340E103 | Stock | 15,000 | $318,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 30,000 | $299,000 | thousands by filing date | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 30,000 | $274,000 | thousands by filing date | |
| PIONEER NATURAL RESOURCES CO | 723787107 | COM | 3,800 | $267,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 30,000 | $230,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 8,000 | $214,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 10,000 | $184,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 15,000 | $148,000 | thousands by filing date | |
| YIELD10 BIOSCIENCE INC | 98585K102 | COM | 18,952 | $71,000 | thousands by filing date | |
| WORKHORSE GROUP INC | 98138J206 | COM NEW | 25,000 | $45,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 20,000 | $40,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001618205-20-000002 | this filing | 2020-05-12 | acceptance time not in the bulk data set |